Mr. Speaker, I thank the hon. member for his comments. He reflects the concerns of most Canadians when they look at the issue.
The stem cell issue is so new that people do not know enough about it. They want to know more. They cannot understand the difference between umbilical cord stem cells, stem cells from fat and muscle, adult stem cells, embryonic stem cells and what they all entail. It is complex and difficult to understand. Part of Bill C-56 deals with this. The other part deals with reproduction. The bill has a reproduction side and a science side.
With respect to the bill's science side, if we look forward into the 21st century one of the most important parts of Bill C-56 is the regulatory regime that would license controlled activities in the area. Could my hon. colleague comment on the regulatory body and how important it is that it garner the trust of Canadians? He has been a member of the House for quite some time and understands the importance of the issue.